NIOX Group Plc (AIM:NIOX)
64.60
+1.00 (1.57%)
Jul 27, 2026, 5:06 PM GMT
NIOX Group Revenue
In the year 2025, NIOX Group had annual revenue of 48.70M GBP with 16.51% growth. NIOX Group had revenue of 23.50M in the half year ending December 31, 2025, with 30.56% growth.
Revenue
48.70M
Revenue Growth
+16.51%
P/S Ratio
5.58
Revenue / Employee
502.06K
Employees
97
Market Cap
271.77M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 48.70M | 6.90M | 16.51% |
| Dec 31, 2024 | 41.80M | 5.00M | 13.59% |
| Dec 31, 2023 | 36.80M | 5.50M | 17.57% |
| Dec 31, 2022 | 31.30M | 3.40M | 12.19% |
| Dec 31, 2021 | 27.90M | 4.00M | 16.74% |
| Dec 31, 2020 | 23.90M | -10.70M | -30.92% |
| Dec 31, 2019 | 34.60M | -13.70M | -28.36% |
| Dec 31, 2018 | 48.30M | 2.00M | 4.32% |
| Dec 31, 2017 | 46.30M | 23.20M | 100.43% |
| Dec 31, 2016 | 23.10M | 12.30M | 113.89% |
| Dec 31, 2015 | 10.80M | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
| Dec 31, 2009 | - | - | - |
| Dec 31, 2008 | - | - | - |
| Dec 31, 2007 | - | - | - |
| Dec 31, 2006 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 45.77B |
| GSK plc | 32.78B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Integrated Diagnostics Holdings | 115.75M |
| Optima Health | 113.75M |
| Animalcare Group | 89.11M |
| Allergy Therapeutics | 57.29M |
NIOX Group News
- 4 months ago - NIOX Group Annual report: H2 2025 - Filings
- 4 months ago - NIOX Group Annual report: H2 2025 - Filings
- 4 months ago - NIOX Group Slides: H2 2025 - Filings
- 6 months ago - Niox Group price target lowered to 86 GBp from 90 GBp at Deutsche Bank - TheFly
- 6 months ago - NIOX Group Earnings release: H2 2025 - Filings
- 10 months ago - NIOX Group Quarterly report: H1 2025 - Filings
- 10 months ago - NIOX Group Slides: H1 2025 - Filings
- 1 year ago - Niox Group upgraded to Buy from Hold at Panmure Liberum - TheFly